Navigation Links
Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
Date:11/24/2013

SAN DIEGO, Nov. 24, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce results of the Light Study interim analysis on Monday, November 25, 2013 prior to market open. Following the announcement, Orexigen management will host a live webcast and conference call at 8:30 a.m. Eastern time (5:30 a.m. Pacific time).

The live call may be accessed by phone by calling (888) 895-5479 (domestic) or (847) 619-6250 (international), participant code 36202424. The webcast can be accessed live on the Investor Relations section of the Orexigen web site at www.orexigen.com and will be archived for 14 days following the call.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application had been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com

McDavid Stilwell
Vice President, Corporate Communications & Business Development
858-875-8600


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
2. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
3. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
4. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
5. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
6. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
7. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
8. Orexigen Therapeutics to Host Second Quarter 2013 Financial Results Conference Call and Webcast
9. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
10. Orexigen Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference
11. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Inc. (NYSE: RMD ) today announced results for ... quarter was $453.1 million, a 9 percent increase compared ... percent increase on a constant currency basis).  Net income ... 30, 2014.  Diluted earnings per share for the quarter ... 2014.  The results for the quarter ...
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... CHAGRIN FALLS, Ohio , July 30, 2015 /PRNewswire/ ... in his OMTEC® 2015 keynote address last month that ... business models in order to gain the efficiencies—and develop ... future. Dr. Barsoum,s comments were preceded by ... Tornier, avid entrepreneur and OMTEC moderator, who stressed that ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... 16 A new application developed by American ... pharmaceuticals has increased health plan staff productivity and the number ... diagnostic imaging benefit management and technology company with health plan ... of WellPoint, Inc. (NYSE: WLP ), adapted the ...
... , GREEN BAY, Wis., Dec. 16 ... Biotech for the use of super absorbency BCM-95® ... formulations. The exclusive distribution territory for these ... channel and professional channel, which includes allopathic doctors, ...
Cached Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3
(Date:7/31/2015)... FL (PRWEB) , ... July 31, 2015 , ... ... and distribution of a wide variety of nutritional and wellness products, announced the ... therapist that specializes in massage therapy, active isolated stretching and the prevention and ...
(Date:7/31/2015)... ... 31, 2015 , ... Intellitec Solutions announced today they have ... Dynamics GP for a senior living facility in Maine. Having achieved recognition as ... in 16 states. This further expansion was again a factor of the firm’s ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and the growing number of individuals who remain undiagnosed, treatment options for patients ... shy away from traditional CPAP therapy due to its overall lack of comfort ...
(Date:7/30/2015)... , ... July 31, 2015 , ... ... Errors By 50% or More, **Presented by FDAnews and Ginette M. Collazo, Inc.**, ... a 15 year veteran of helping drug, biologic and device firms reduce manufacturing ...
(Date:7/30/2015)... , ... July 31, 2015 , ... Committed to helping ... action by asking community members to contribute to the College’s “My Brother’s Keeper Scholarship.” ... our young people stay on track. Providing the support they need to think more ...
Breaking Medicine News(10 mins):Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3
... Reinberg HealthDay Reporter , SUNDAY, Oct. 3 (HealthDay ... are poor or black fare worse than others if they ... financial and racial factors that impact diagnosis, treatment and survival, ... the American Association for Cancer Research in Miami. Lack ...
... October 2010 Elsevier, a world-leading publisher of scientific, technical ... the launch of a new journal, Developmental Cognitive Neuroscience ... will be available at the Society for Neuroscience 40th Annual ... ,It is with a sense of excitement that we ...
... detect small signs of increased tremor and impaired motor ... follow up the treatment of neurological disorders, reveals a ... aim was to investigate whether quantitative measurement methods, in ... detect small changes in tremor or other motor,functions resulting ...
... FRANCISCO O. Marion Burton, MD, FAAP, will serve ... Pediatrics (AAP) beginning Monday, Oct. 4, at the AAP ... in San Francisco. The AAP is the nation,s largest ... pediatricians, pediatric medical subspecialists and pediatric surgical specialists. ...
... Researchers at Queen,s University Belfast have completed one of the ... drug was outlawed earlier this year. They found that the ... the substance. Interviews with 23 mephedrone users were ... the legislation that made the drug illegal in the UK. ...
... Oregon Health &Science University may have uncovered a new ... mother to newborn child. The research, which was led ... will be published in the October 3rd online edition ... "Mother-to-infant transmission of HIV is a tremendous worldwide problem, ...
Cached Medicine News:Health News:Insurance, Race and Poverty Affect Cancer Care, Researchers Report 2Health News:Insurance, Race and Poverty Affect Cancer Care, Researchers Report 3Health News:Elsevier launches new journal: Developmental Cognitive Neuroscience 2Health News:Effective methods for detecting early signs of tremor 2Health News:O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president 2Health News:Study focuses on mephedrone use in Northern Ireland post-ban 2Health News:OHSU research reveals possible method for boosting the immune system to protect infants against HIV 2Health News:OHSU research reveals possible method for boosting the immune system to protect infants against HIV 3
...
... features an advanced design that accommodates both ... gives surgeons the flexibility to easily customize ... is built-in to every aspect of the ... Secure-Twist anti-migration system to the screw options ...
... is designed to meet the clinical challenges ... attached locking mechanism and the choice of ... variable angle screws for ease of implantation ... plate system allows the surgeon the versatility ...
... Revolutions start with small things. ... is one of the trailblazers of ... reflecting the,trend towards ever smaller access ... the operation site. ,The HiLAN XS ...
Medicine Products: